‹ All questions

Elevance Health vs Humana: which stock is doing better?

Elevance Health and Humana are business rivals. Where they compete: medicare Advantage, Medicaid, and employer group health insurance plans. Here is how the two stocks, and the businesses behind them, compare over the past year.

Updated Oct 9, 2026

60
ELV P3

Close call

On Stox’s P3 score, Elevance Health rates 60 and Humana 57, too close to call. Over the past year Elevance Health is +14% and Humana +45%, against +16% for the S&P 500. Humana has grown revenue faster, +14% against +9%. Elevance Health swings less, about 3.0% on a typical day against 3.8%. By type, Elevance Health is a Bellwether and Humana a Faith Trade.

ELV P3 60HUM P3 57Both in Aerospace-defense

The past year

ELV against HUM, each set to $100 a year ago. Select a measure in the table below to chart it for both.

ELV against HUM, past year
$100 a year ago. ELV +14%, HUM +45%.
100150NovDecJanFebMarAprMayJunJulAugSepOct
ELVHUM

ELV and HUM side by side

Ahead marks the stronger reading on each line; for the typical day and the deepest fall it marks the steadier stock. Select a row with a chart to see both over the year.

MeasureELVHUMAhead
Past 3 months
Share price change
−3%+6%HUM
Past month
Share price change
−1%+8%HUM
Revenue growth
Past four quarters against the year before
+9%+14%HUM
Operating margin
Operating profit as a share of revenue, past four quarters
4%1%ELV
Deepest fall
From a high, past year
−26%−45%ELV, held up
Market value
What the market values the company at
$89.5B$51.8B
Type
Its Stox Atlas type
BellwetherFaith Trade
Group
Stocks it moves with
Aerospace-defenseAerospace-defenseSame group

How to read this page

How it’s measured. Scores from Stox rank each stock against about 1,200 large US stocks and funds, where 100 is best; P3 combines market beat, staying power and business growth. Returns are share-price changes. The typical day is the average true range over 14 days as a share of the price, averaged over the past year.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and curated rivals from Stox.

A higher score describes a stronger past year, not what comes next.

Rivals are chosen by the markets the two businesses compete in, not by sector labels.

For financial statements, valuation and news, see ELV and HUM on Stox.

This page is information, not investment advice. About our data and methods ›

More head-to-heads

See all questions ›